Paper34502425
NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases-Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome.
Zarobkiewicz MK and 4 others. Int J Mol Sci, 2021. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases-Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome. Papers, record 34502425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34502425
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases-Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Guillain-Barre Syndrome | Major topic |
| Killer Cells, Natural | Major topic |
| Multiple Sclerosis | Major topic |
| Myasthenia Gravis | Major topic |
| Natural Killer T-Cells | Major topic |
| Animals | |
| Humans | |
| Inflammation |
Source PubMed
References113
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9815265 | CD4(+) T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice. | J Exp Med | 1998 | https://conductscience.org/library/papers/9815265 | PubMed |
| 2 | 16260117 | Genetics of autoimmune myasthenia gravis: the multifaceted contribution of the HLA complex. | J Autoimmun | 2005 | https://conductscience.org/library/papers/16260117 | PubMed |
| 3 | 12055208 | Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. | J Immunol | 2002 | https://conductscience.org/library/papers/12055208 | PubMed |
| 4 | 12578858 | Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. | Int Immunol | 2003 | https://conductscience.org/library/papers/12578858 | PubMed |
| 5 | 22694000 | Guillain-Barré syndrome. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22694000 | PubMed |
| 6 | 18684921 | Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner. | J Immunol | 2008 | https://conductscience.org/library/papers/18684921 | PubMed |
| 7 | 29623561 | NKT cells in liver diseases. | Front Med | 2018 | https://conductscience.org/library/papers/29623561 | PubMed |
| 8 | 33360376 | Reading the room: iNKT cells influence B cell responses. | Mol Immunol | 2021 | https://conductscience.org/library/papers/33360376 | PubMed |
| 9 | 23475484 | [NKT cells: their development, mechanisms and effects of action]. | Postepy Hig Med Dosw (Online) | 2013 | https://conductscience.org/library/papers/23475484 | PubMed |
| 10 | 30185660 | 1,25-Dihydroxyvitamin D suppresses M1 macrophages and promotes M2 differentiation at bone injury sites. | JCI Insight | 2018 | https://conductscience.org/library/papers/30185660 | PubMed |
| 11 | 29593743 | Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity. | Front Immunol | 2018 | https://conductscience.org/library/papers/29593743 | PubMed |
| 12 | 27766432 | Multiple sclerosis: experimental models and reality. | Acta Neuropathol | 2017 | https://conductscience.org/library/papers/27766432 | PubMed |
| 13 | 30984164 | Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies. | Front Immunol | 2019 | https://conductscience.org/library/papers/30984164 | PubMed |
| 14 | 20139988 | Raising the NKT cell family. | Nat Immunol | 2010 | https://conductscience.org/library/papers/20139988 | PubMed |
| 15 | 20565885 | A systematic review of population based epidemiological studies in Myasthenia Gravis. | BMC Neurol | 2010 | https://conductscience.org/library/papers/20565885 | PubMed |
| 16 | 1634612 | Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis. | J Clin Invest | 1992 | https://conductscience.org/library/papers/1634612 | PubMed |
| 17 | 11748281 | Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. | J Exp Med | 2001 | https://conductscience.org/library/papers/11748281 | PubMed |
| 18 | 23266520 | Infectome: a platform to trace infectious triggers of autoimmunity. | Autoimmun Rev | 2013 | https://conductscience.org/library/papers/23266520 | PubMed |
| 19 | 25449931 | Ocular myasthenia gravis: a review. | Indian J Ophthalmol | 2014 | https://conductscience.org/library/papers/25449931 | PubMed |
| 20 | 25864758 | Research on the influence of α-GalCer activating experimental autoimmune myasthenia gravis mice NKT cells at different times on myasthenia gravis. | J Biol Regul Homeost Agents | 2015 | https://conductscience.org/library/papers/25864758 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42910324 | Natural killer T cells as therapeutic targets for neuroinflammatory disorders. | Anim Cells Syst (Seoul) | 2026 | https://conductscience.org/library/papers/42910324 | PubMed |
| 41961712 | Causal effects of Epstein-Barr virus antibodies on autoimmune neuroinflammatory diseases: A generalised summary data-based Mendelian randomisation study. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/41961712 | PubMed |
| 41861096 | Revisiting T cells: Innate actions and emerging links to innate memory response. | J Immunol | 2026 | https://conductscience.org/library/papers/41861096 | PubMed |
| 40933372 | An impact of type 2 diabetes mellitus on NKT-like cell population in humans: a new insight into impaired immune response in hyperglycemia. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40933372 | PubMed |
| 40583406 | NKT cells-a generalist in disease treatment and a new key to unlock immunotherapy. | Immunotherapy | 2025 | https://conductscience.org/library/papers/40583406 | PubMed |
| 40012853 | Editorial: Neuroinflammatory aspects in neurological disorders. | Front Mol Med | 2025 | https://conductscience.org/library/papers/40012853 | PubMed |
| 39518994 | The Absence of Thyroid-Stimulating Hormone Receptor Expression on Natural Killer T Cells: Implications for the Immune-Endocrine Interaction. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39518994 | PubMed |
| 38774868 | Identification of immune subsets with distinct lectin binding signatures using multi-parameter flow cytometry: correlations with disease activity in systemic lupus erythematosus. | Front Immunol | 2024 | https://conductscience.org/library/papers/38774868 | PubMed |
| 38477945 | A Humanized Mouse Model Coupled with Computational Analysis Identifies Potent Glycolipid Agonist of Invariant NKT Cells. | ACS Chem Biol | 2024 | https://conductscience.org/library/papers/38477945 | PubMed |
| 38463658 | Unremitting pro-inflammatory T-cell phenotypes, and macrophage activity, following paediatric burn injury. | Clin Transl Immunology | 2024 | https://conductscience.org/library/papers/38463658 | PubMed |
| 38310449 | Harnessing Chimeric Antigen Receptor-engineered Invariant Natural Killer T Cells: Therapeutic Strategies for Cancer and the Tumor Microenvironment. | Curr Pharm Biotechnol | 2024 | https://conductscience.org/library/papers/38310449 | PubMed |
| 38213874 | The Plasticity of Immune Cell Response Complicates Dissecting the Underlying Pathology of Multiple Sclerosis. | J Immunol Res | 2024 | https://conductscience.org/library/papers/38213874 | PubMed |
| 37853155 | Exploring Natural Killer Cell Testing in Embryo Implantation and Reproductive Failure: An Overview of Techniques and Controversies. | Reprod Sci | 2024 | https://conductscience.org/library/papers/37853155 | PubMed |
| 37153617 | Novel potential therapeutic targets of alopecia areata. | Front Immunol | 2023 | https://conductscience.org/library/papers/37153617 | PubMed |
| 37082729 | Dysfunction of circulating CD3+CD56+ NKT-like cells in type 2 diabetes mellitus. | Int J Med Sci | 2023 | https://conductscience.org/library/papers/37082729 | PubMed |
| 36769064 | Natural Killer T-like Cells: Immunobiology and Role in Disease. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36769064 | PubMed |
| 36629999 | Decreased natural killer T-like cells correlated to disease activity in systemic lupus erythematosus. | Clin Rheumatol | 2023 | https://conductscience.org/library/papers/36629999 | PubMed |
| 36263021 | A humanized mouse model for in vivo evaluation of invariant Natural Killer T cell responses. | Front Immunol | 2022 | https://conductscience.org/library/papers/36263021 | PubMed |
| 35619713 | The Effect of Peripheral Immune Cell Counts on the Risk of Multiple Sclerosis: A Mendelian Randomization Study. | Front Immunol | 2022 | https://conductscience.org/library/papers/35619713 | PubMed |
| 35548667 | MicroRNAs as T Lymphocyte Regulators in Multiple Sclerosis. | Front Mol Neurosci | 2022 | https://conductscience.org/library/papers/35548667 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34502425
GET https://conductscience.org/api/papers/v1/34502425/references?page=2